Silvija Kraljevic
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis 6
-
- Colorectal Cancer Treatments and Studies 4
- Lung Cancer Research Studies 3
-
- Lung Cancer Treatments and Mutations 4
- Renal cell carcinoma treatment 2
-
- Cancer Genomics and Diagnostics 3
- Cancer, Hypoxia, and Metabolism 2
-
- Cancer therapeutics and mechanisms 1
Silvija Kraljevic
15 papers receiving 322 citations
Peers
Comparison fields: 5 of 40
- Hepatology 157
- Oncology 178
- Pathology and Forensic Medicine 83
- Pulmonary and Respiratory Medicine 142
- Cancer Research 56
Countries citing papers authored by Silvija Kraljevic
This map shows the geographic impact of Silvija Kraljevic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvija Kraljevic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvija Kraljevic more than expected).
Fields of papers citing papers by Silvija Kraljevic
This network shows the impact of papers produced by Silvija Kraljevic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvija Kraljevic. The network helps show where Silvija Kraljevic may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Silvija Kraljevic, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2021 | 48 | |
| 3 | 2021 | 31 | |
| 4 | 2019 | 19 | |
| 5 | 2018 | 1 | |
| 6 | 2018 | 104 | |
| 7 | 2018 | 25 | |
| 8 | 2017 | 5 | |
| 9 | 2017 | 2 | |
| 10 | 2017 | 60 | |
| 11 | 2017 | 4 | |
| 12 | 2013 | 8 | |
| 13 | 2010 | 2 | |
| 14 | 2009 | 15 | |
| 15 | [Low molecular weight heparin (dalteparin) in treatment of patients with thromboembolism incidents]. | 2001 | 2 |
About Silvija Kraljevic
Silvija Kraljevic is a scholar working on Hepatology, Internal Medicine and Cancer Research, having authored 15 papers that have together received 327 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Colorectal Cancer Treatments and Studies (4 papers), Lung Cancer Treatments and Mutations (4 papers), Cancer Genomics and Diagnostics (3 papers), Lung Cancer Research Studies (3 papers), Renal cell carcinoma treatment (2 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Cancer therapeutics and mechanisms (1 paper). The work is most often cited by research in Hepatology (157 citations), Oncology (178 citations) and Pathology and Forensic Medicine (83 citations). Silvija Kraljevic has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include Masatoshi Kudo, Richard S. Finn, Max W. Sung, Ari David Baron, Masafumi Ikeda, Tomoki Kubota, Kohei Ishikawa, Abby B. Siegel, Takuji Okusaka and Andrew X. Zhu. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Clinical Cancer Research, Clinical Lung Cancer and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.